Cargando…

Comparison of Ablation Area and Change in Functional Liver Reserve after Radiofrequency Ablation for Hepatocellular Carcinoma Using the arfa(®) and VIVA(®) Systems

Radiofrequency ablation (RFA) is recommended in Japan for patients with hepatocellular carcinomas (HCCs) one to three in number and ≤3 cm in size. The arfa(®) and VIVA(®) RFA systems are widely used for patients with HCC and this retrospective observational study aims to compare their performances....

Descripción completa

Detalles Bibliográficos
Autores principales:	Takaya, Hiroaki, Namisaki, Tadashi, Matsumoto, Kazusuke, Suzuki, Junya, Murata, Koji, Tsuji, Yuki, Nakanishi, Keisuke, Kaji, Kosuke, Kitade, Mitsuteru, Noguchi, Ryuichi, Yoshiji, Hitoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780974/ https://www.ncbi.nlm.nih.gov/pubmed/35054128 http://dx.doi.org/10.3390/jcm11020434

Ejemplares similares

Clinical Experience of Percutaneous Radiofrequency Ablation Using an arfa RF ABLATION SYSTEM(Ⓡ) in Various Organs
por: Kinota, Naoya, et al.
Publicado: (2022)

Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients
por: Takaya, Hiroaki, et al.
Publicado: (2019)

Novel oral plasminogen activator inhibitor-1 inhibitor TM5275 attenuates hepatic fibrosis under metabolic syndrome via suppression of activated hepatic stellate cells in rats
por: Noguchi, Ryuichi, et al.
Publicado: (2020)

VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma
por: Takaya, Hiroaki, et al.
Publicado: (2019)

Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B
por: Noguchi, Ryuichi, et al.
Publicado: (2017)

Hydralazine Sensitizes to the Antifibrotic Effect of 5-Aza-2′-deoxycytidine in Hepatic Stellate Cells
por: Asada, Kiyoshi, et al.
Publicado: (2020)

Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model
por: DOUHARA, AKITOSHI, et al.
Publicado: (2015)

Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis
por: Tsuji, Yuki, et al.
Publicado: (2020)

ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma
por: Takaya, Hiroaki, et al.
Publicado: (2019)

The vascular endothelial growth factor (VEGF) receptor-2 is a major regulator of VEGF-mediated salvage effect in murine acute hepatic failure
por: Namisaki, Tadashi, et al.
Publicado: (2010)

Periostin cross-reacts with the renin-angiotensin system during liver fibrosis development
por: Takeda, Kosuke, et al.
Publicado: (2017)

Oral administration of fructose exacerbates liver fibrosis and hepatocarcinogenesis via increased intestinal permeability in a rat steatohepatitis model
por: Seki, Kenichiro, et al.
Publicado: (2018)

Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity
por: Kaji, Kosuke, et al.
Publicado: (2017)

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis
por: Ozutsumi, Takahiro, et al.
Publicado: (2020)

Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat
por: Yoshiji, Hitoshi, et al.
Publicado: (2009)

Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model
por: Nakanishi, Keisuke, et al.
Publicado: (2019)

Acyclic retinoid and angiotensin-II receptor blocker exert a combined protective effect against diethylnitrosamine-induced hepatocarcinogenesis in diabetic OLETF rats
por: Nishimura, Norihisa, et al.
Publicado: (2018)

DNA methylation of angiotensin II receptor gene in nonalcoholic steatohepatitis-related liver fibrosis
por: Asada, Kiyoshi, et al.
Publicado: (2016)

Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on hepatic fibrosis
por: Namisaki, Tadashi, et al.
Publicado: (2017)

Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis
por: Fujinaga, Yukihisa, et al.
Publicado: (2022)

Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B
por: Tsuji, Yuki, et al.
Publicado: (2020)

Calcified mucinous adenocarcinoma of the stomach metastatic to the iris: a case report
por: Kaneko, Miki, et al.
Publicado: (2019)

Mechanism of ribosome rescue by ArfA and RF2
por: Demo, Gabriel, et al.
Publicado: (2017)

Glycogenic Hepatopathy in Type 1 Diabetes Mellitus
por: Asada, Shohei, et al.
Publicado: (2017)

A Patient with Hepatocellular Carcinoma with Isolated Right Atrial Metastases
por: Takaya, Hiroaki, et al.
Publicado: (2017)

Radiofrequency ablation devices
por: Navaneethan, Udayakumar, et al.
Publicado: (2017)

Radiofrequency Ablation for Adenomyosis
por: Dedes, Ioannis, et al.
Publicado: (2023)

Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma
por: Kwak, Min Hwan, et al.
Publicado: (2022)

Comparison of Wet Radiofrequency Ablation with Dry Radiofrequency Ablation and Radiofrequency Ablation Using Hypertonic Saline Preinjection: Ex Vivo Bovine Liver
por: Lee, Jeong Min, et al.
Publicado: (2004)

Rifaximin enhances the L-carnitine-mediated preventive effects on skeletal muscle atrophy in cirrhotic rats by modulating the gut-liver-muscle axis
por: Murata, Koji, et al.
Publicado: (2022)

Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
por: Sato, Shinya, et al.
Publicado: (2019)

Association between Equol Production Status and Nonalcoholic Steatohepatitis
por: Akahane, Takemi, et al.
Publicado: (2021)

Percutaneous Radiofrequency Ablation for Liver Tumors: Technical Tips
por: Sato, Yozo, et al.
Publicado: (2020)

The role of hepatic reserve in the mortality of cirrhotic patients with small hepatocellular carcinoma receiving radiofrequency ablation
por: Hung, Tsung-Hsing, et al.
Publicado: (2022)

Efficacy of microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score analysis
por: Suwa, Kanehiko, et al.
Publicado: (2021)

Radiofrequency Ablation In Ventricular Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2008)

Temperature Controlled Radiofrequency Ablation
por: Eick, Olaf J
Publicado: (2002)

Radiofrequency ablation of lung tumours
por: Bargellini, Irene, et al.
Publicado: (2011)

Radiofrequency ablation of lung tumours
por: Goh, PYT
Publicado: (2006)

Radiofrequency Ablation of Adenoma Sebaceum
por: Swaroop MR,, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_lnv753cdrohsh0hgnl9gofimko